(S)-2-(3-(4-hexylphenyl)-1,2,4-oxadiazol-5-yl)azetidine-1-carboximidamide hydrochloride

ID: ALA3627772

Chembl Id: CHEMBL3627772

PubChem CID: 122192893

Max Phase: Preclinical

Molecular Formula: C18H26ClN5O

Molecular Weight: 327.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCc1ccc(-c2noc([C@@H]3CCN3C(=N)N)n2)cc1.Cl

Standard InChI:  InChI=1S/C18H25N5O.ClH/c1-2-3-4-5-6-13-7-9-14(10-8-13)16-21-17(24-22-16)15-11-12-23(15)18(19)20;/h7-10,15H,2-6,11-12H2,1H3,(H3,19,20);1H/t15-;/m0./s1

Standard InChI Key:  ZFDBMAQVTGRRFB-RSAXXLAASA-N

Associated Targets(Human)

SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sphk2 Sphingosine kinase 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.43Molecular Weight (Monoisotopic): 327.2059AlogP: 3.50#Rotatable Bonds: 7
Polar Surface Area: 92.03Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.11CX LogP: 4.50CX LogD: 2.03
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.46Np Likeness Score: -0.84

References

1. Congdon MD, Childress ES, Patwardhan NN, Gumkowski J, Morris EA, Kharel Y, Lynch KR, Santos WL..  (2015)  Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.,  25  (21): [PMID:25862200] [10.1016/j.bmcl.2015.03.041]

Source